Pharmaceutical heavyweights Pfizer and Allergan have unveiled a record-setting $US160 billion ($A222.62 billion) mega-merger as US stocks finished modestly lower.

Pharmaceutical heavyweights Pfizer and Allergan have unveiled a record-setting $US160 billion ($A222.62 billion) mega-merger as US stocks finished modestly lower.